Department of Orthopaedic Surgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Sports Health. 2012 Jul;4(4):319-27. doi: 10.1177/1941738112439686.
Pain control is a factor in the sideline treatment of competitive athletes. Ketorolac injections by team physicians as a pain control measure are seemingly becoming more mainstream, although there have been very little data published on its use.
Intramuscular ketorolac injections are being used regularly by orthopaedic surgeons and primary care sports medicine physicians in their care of athletes.
Descriptive epidemiology study.
A 19-question survey was generated online for physician members of the American Orthopaedic Society for Sports Medicine, the Arthroscopy Association of North America, and the American Medical Society for Sports Medicine. The survey link was e-mailed, with reminders sent every 1 to 2 weeks, and results were collected from April to June 2011.
The survey was e-mailed to 6950 physicians, with 1100 respondents completing it (60% orthopaedic surgeons, 40% nonsurgical sports medicine physicians). Approximately 49% use intramuscular ketorolac in the treatment of athletes, primarily at the collegiate and professional levels; 95.8% reported effective pain control after administration; 2.9% reported bleeding complications; and 1.9% reported kidney complications from its use.
Intramuscular ketorolac injections are used by approximately half of all team physicians in their sideline treatment of competitive athletes.
疼痛控制是竞技运动员场外治疗的一个因素。队医使用酮咯酸注射作为止痛措施似乎越来越普遍,尽管关于其使用的数据很少。
肌肉内注射酮咯酸被矫形外科医生和初级保健运动医学医生常规用于运动员的治疗。
描述性流行病学研究。
为美国矫形外科医师学会运动医学分会、北美关节镜协会和美国运动医学学会的医师成员在线生成了一份 19 个问题的调查。通过电子邮件发送调查链接,并每 1 到 2 周发送提醒,从 2011 年 4 月到 6 月收集结果。
该调查通过电子邮件发送给 6950 名医生,有 1100 名医生完成了调查(60%为矫形外科医生,40%为非手术运动医学医生)。约 49%的医生在治疗运动员时使用肌肉内酮咯酸,主要在大学和职业水平;95.8%的医生报告说在给药后疼痛得到有效控制;2.9%的医生报告说有出血并发症;1.9%的医生报告说使用后有肾脏并发症。
大约一半的队医在治疗竞技运动员的场外治疗中使用肌肉内酮咯酸注射。